AnRes Clinical ApS: Financial statements 2020
CVR: 41147504
Source: annual report 2020, Danish Business Authority
05/02/2020 – 31/12/2020
AnRes Clinical ApS (CVR 41147504) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 805,782 and a net result of DKK 437,527. Equity in the 2020 report amounted to DKK 477,527. The solvency ratio was 58.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 805,782
- Profit/Loss
- DKK 437,527
- Equity
- DKK 477,527
- Total Assets
- DKK 812,637
- Employees
- 2
Official annual report
How creditworthy is AnRes Clinical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of February 5, 2020, Anna Katarzyna Polak is registered as director of AnRes Clinical ApS.
As of February 5, 2020, Anna Katarzyna Polak is registered as an owner of AnRes Clinical ApS with an ownership share of 100%.
AnRes Clinical ApS was founded on February 5, 2020.
About AnRes Clinical ApS
AnRes Clinical ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Anna Katarzyna Polak. The company is owned by Anna Katarzyna Polak. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,457,177 and a net result of DKK 286,285 compared with DKK 1,120,314 the year before. Equity in the 2025 report amounted to DKK 2,306,048.